Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease
Authors:
- 21 May 2018
- journal article
- research article
- Published by Springer Nature in Lung
- Vol. 196 (4) , 409-416
Abstract
The gender, age, and lung physiology (GAP) model, interstitial lung diseases—GAP (ILD-GAP) model, and the smoking history, age, and diffusion capacity of the lung (SADL) model were compared using a systemic sclerosis-ILD (SSc-ILD) cohort to evaluate which best determined prognosis.Keywords
Funding Information
- National Center for Advancing Translational Sciences (UL1 TR000135)
This publication has 31 references indexed in Scilit:
- Mortality Risk Prediction in Scleroderma-Related Interstitial Lung DiseaseChest, 2017
- Short‐Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic SclerosisArthritis & Rheumatology, 2017
- Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialThe Lancet Respiratory Medicine, 2016
- Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) — Report from OMERACT CTD-ILD Working GroupThe Journal of Rheumatology, 2015
- Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosisRespiratory Medicine, 2014
- Predicting Survival Across Chronic Interstitial Lung DiseaseChest, 2014
- 6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2013
- A Multidimensional Index and Staging System for Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 2012
- Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studiesRheumatology, 2011
- Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011